  In order to find effective treatments for Alzheimer's disease (AD), we need
to identify subjects at risk of AD as early as possible. To this end, recently
developed disease progression models can be used to perform early diagnosis, as
well as predict the subjects' disease stages and future evolution. However,
these models have not yet been applied to rare neurodegenerative diseases, are
not suitable to understand the complex dynamics of biomarkers, work only on
large multimodal datasets, and their predictive performance has not been
objectively validated. In this work I developed novel models of disease
progression and applied them to estimate the progression of Alzheimer's disease
and Posterior Cortical atrophy, a rare neurodegenerative syndrome causing
visual deficits. My first contribution is a study on the progression of
Posterior Cortical Atrophy, using models already developed: the Event-based
Model (EBM) and the Differential Equation Model (DEM). My second contribution
is the development of DIVE, a novel spatio-temporal model of disease
progression that estimates fine-grained spatial patterns of pathology,
potentially enabling us to understand complex disease mechanisms relating to
pathology propagation along brain networks. My third contribution is the
development of Disease Knowledge Transfer (DKT), a novel disease progression
model that estimates the multimodal progression of rare neurodegenerative
diseases from limited, unimodal datasets, by transferring information from
larger, multimodal datasets of typical neurodegenerative diseases. My fourth
contribution is the development of novel extensions for the EBM and the DEM,
and the development of novel measures for performance evaluation of such
models. My last contribution is the organization of the TADPOLE challenge, a
competition which aims to identify algorithms and features that best predict
the evolution of AD.
